NEW YORK, Dec 15 – The microarray industry is poised to explode over the next few year, Dain Rauscher Wessels said in a report issued Friday.

" We foresee the current $600 million market opportunity afforded to DNA microarray technology to grow to $4.5 billion by 2004," genomics equity analyst Todd Nelson wrote in a report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.